微等离子体治疗面部血管瘤放射治疗后萎缩性瘢痕的临床效果

Clinical efficacy of isotopes radiotherapy with micro-plasma on atrophic scars of facial hemangioma

目的 探讨微等离子体治疗面部血管瘤放射性核素放疗后萎缩性瘢痕的临床效果.方法 将52例患者采用微等离子体进行治疗,功率设置为60～80 W,每6周治疗1次,共治疗4次,通过治疗前后统一衡量标准对比进行疗效评估.结果 52例患者萎缩性瘢痕总有效率为82.7％.痊愈28例（53.8％）,显效15例（28.9％）,有效9例（17.3％）,无效0例.色素沉着总有效率为90.3％.痊愈31例（59.6％）,显效16例（30.8％）,有效5例（9.6％）,无效0例.结论 微等离子体能显著改善面部血管瘤放射性核素放疗后萎缩性瘢痕的凹陷程度,同时还能显著消除瘢痕的色素沉着,改善瘢痕色泽,是治疗的有效方法.

Objective To study the clinical efficacy of treatment of atrophic scars of facial hemangioma after isotopes radiotherapy with micro-plasma.Methods A total of 52 patients with atrophic scars were selected under micro-plasma treatment for 4 times,one time every six weeks.And their efficacies were evaluated by compared with single standard of that before and after the treatment.Results By means of rate of clinical index,the total effective rate of atrophic scars was 82.7%.The degree of improvement was as follows：cured in 53.8%,marked effective in 28.9%,effective in 17.3% and no case ineffective.The total effective rate of hyperpigmentation was 90.3%,including cured in 59.6%,marked effective in 30.8%,effective in 9.6% and no ineffective cases.Conclusions Micro-plasma is an effective therapy for atrophic scars of facial hemangioma after isotopes radiotherapy,which can significantly improve the depression degree of scars,eliminate the hyperpigmentation and improve the color of scars,but it only has adverse reactions of wound pain and postoperative wound erythema.